Company news
Eton Pharmaceuticals, Inc. news in 2021
Eton Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)
December 19, 2021
Eton Pharmaceuticals Reports Third Quarter Financial Results
November 14, 2021
Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®
November 14, 2021
Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral Solution
November 7, 2021
Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
November 2, 2021
Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic Acid
October 27, 2021
Eton Pharmaceuticals Reports Second Quarter Financial Results
August 15, 2021
Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
August 2, 2021
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
June 14, 2021
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
June 14, 2021
Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection
May 27, 2021
Eton Pharmaceuticals Reports Record Revenue and Earnings
May 12, 2021
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
May 3, 2021
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
March 16, 2021
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
March 15, 2021
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021
March 3, 2021
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
February 15, 2021
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
February 7, 2021
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
January 13, 2021
Calls in 2021
- Eton Pharmaceuticals (NASDAQ:ETON) Q3 2021 Earnings Call
Nov 15, 2021
Transcript - Eton Pharmaceuticals (NASDAQ:ETON) Q2 2021 Earnings Call
Aug 16, 2021
Transcript - Eton Pharmaceuticals (NASDAQ:ETON) Q4 2020 Earnings Call
May 16, 2021
Transcript - Eton Pharmaceuticals (NASDAQ:ETON) Q1 2021 Earnings Call
May 13, 2021
Transcript